SA3768111: Baxter DuploSpray MIS Spray Set 360° Endoscopic Applicator w/Snap Lock 5mm x 40cm

In-Date » Baxter » Hemostasis & Sealants

Baxter DuploSpray MIS Spray Set 360° Endoscopic Applicator w/Snap Lock

The Baxter DuploSpray MIS Spray Set SA3768111 is a minimally invasive 360° endoscopic applicator designed for precise and even distribution of hemostatic sealants during laparoscopic procedures. Featuring a 5mm diameter and 40cm length, this applicator allows for optimal reach and maneuverability through standard trocars. The integrated snap lock mechanism ensures secure attachment to compatible Duploject systems for controlled dual-spray delivery.

Product Code: SA3768111

• Diameter: 5mm
• Length: 40cm
• Spray Pattern: 360° Circular Dispersion
• Connection: Snap Lock
• Compatibility: For Use with Baxter DuploSpray/Duploject Systems

Contents

• 1 Endoscopic Spray Applicator, 5mm x 40cm

Sterilization

• Device Packaged as Sterile: Yes
• Requires Sterilization Prior to Use: No

Additional Details

• Brand: Baxter Micromedics
• Category: Hemostasis
• Type: Endoscopic Sealant Applicator
• FDA Product Code: GCJ
• FDA Product Code Name: Laparoscope, General & Plastic Surgery
• GMDN Term Code: 58451
• GMDN Term Name: Fibrin sealant biochemical preparation/application kit, endoscopic
• GMDN Term Definition: A collection of sterile devices designed to be used for the biochemical preparation and subsequent delivery of autologous fibrin sealant to a site of intervention during an endoscopic surgical procedure (e.g., to achieve haemostasis, seal air leaks, adhere tissues). It typically consists of a dedicated preparation unit (a cassette) with a collection of application devices including an endoscopic applicator, needle, and tubing. Patient blood is contained within the preparation unit which is placed in a production unit (processor) which controls the biochemical processes and centrifugation to produce the fibrin sealant. This is a single-use device.

Baxter provides a broad portfolio of essential healthcare products, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; and surgical hemostat and sealant products. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.